Ebola Vaccine trials Successful
The first study of two separate vaccines against the ebola virus has found that they can both protect against the haemorrhagic fever for at least a year.
The research, that was published in the new England journal of medicine and conducted in Liberia involved 1,500 patients .
Those who were given the vaccines had a powerful antibody response for a year. The trial suggests that both vaccines could be used to save lives in any future epidemic of the disease.
Ebola killed more than 11,000 people in Liberia, Sierra Leone and Guinea in an outbreak in 2014-15.